Francesco Maura, MD, discusses the challenges of whole-genome sequencing in multiple myeloma.
Francesco Maura, MD
Advertisement
Articles by Francesco Maura, MD
Francesco Maura, MD, discusses the significance of studying genomic defining events in patients with multiple myeloma.
Advertisement
Latest Updated Articles
Dr. Maura on the Challenges of Whole-Genome Sequencing in Multiple MyelomaPublished: May 3rd 2021 | Updated:
Dr. Maura on the Significance of Studying Myeloma Genomic Defining EventsPublished: April 26th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma
5